Attached files

file filename
10-K - FORM 10-K - Probility Media Corp2015may31-pbya_10k.htm
EX-31.2 - EX-31.2 - Probility Media Corpex-31_2.htm
EX-10.4 - EX-10.4 - Probility Media Corpex-10_4.htm
EX-31.1 - EX-31.1 - Probility Media Corpex-31_1.htm
EX-10.5 - EX-10.5 - Probility Media Corpex-10_5.htm
Exhibit 32.1
 
 
CERTICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINCIAL OFFICER
Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to
Section 906 of the Sarbane-Oxley Act of 2002



I, Evan Levine, Chief Executive Officer, certify, as of the date hereof, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Annual Report of Panther Biotechnology, Inc. on Form 10-K for the fiscal year ended May 31, 2015 fully complies with the requirements of Section 13(a) or 15(d) of the Securities & Exchange Act of 1934 and that the information contained in the Form 10-K fairly presents in all material respects the financial condition and results of operations of Panther Biotechnology, Inc. at the dates and the periods indicated.
 
Date:  January 22, 2016
 
By /s/ Evan Levine
 
Evan Levine
 
Chief Executive Officer

I, Philip E. Ruben Chief Financial Officer, certify, as of the date hereof, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Annual Report of Panther Biotechnology, Inc. on Form 10-K for the fiscal year ended May 31, 2015 fully complies with the requirements of Section 13(a) or 15(d) of the Securities & Exchange Act of 1934 and that the information contained in the Form 10-K fairly presents in all material respects the financial condition and results of operations of Panther Biotechnology, Inc. at the dates and the periods indicated.
 
Date:  January 22, 2016
 
By /s/ Philip E. Ruben
 
Philip E. Ruben
 
Chief Financial Officer